Where Deep Learning Ends Deep Thinking Begins.

Mind + Machine vs Disease

Oxford Immune Algorithmics (OIA) is a biotech company that builds upon and creates responsible Artificial Intelligence technology to probe the inner workings of the human own sophisticated machinery, the immune system. Enabled by the synergy of human experts and cutting-edge AI algorithms, OIA helps healthcare professionals monitor patients, reduce costs, and make decisions based on their personalised immune profiles. ​With its technology, OIA pushes the boundaries of what is currently possible in the common practice of medicine,  helping health organisations by devising diagnostic support systems that surpass both human experts and standard computer algorithms in their grasp of cause-effect relations, causality being central to diagnosis and prognosis. 
​

Modern Healthcare Technology

On the one hand, science & technology have made some impressive progress towards the future of biology & medicine. For example, the human genome project at a cost of a billion USD when it was finished in 2003. Today, home kits able to do the same cost less than 400 USD. On the other hand, this technology is still highly elitist being performed and exploited only in a small fraction of cases; and, when performed at home, often useless when not medically motivated. In contrast, visits to the point of entry to the healthcare system are often not very different in spite of these many technological developments. How can OIA help close this paradoxical gap?

---

Responsible AI To Screen the Human Immune System

By actively collecting data and creating responsible superhuman AI technology for use in medical applications, we enable health professionals and individuals to reach early diagnoses and thereby prevent conditions and avoid often expensive and deadly post-diagnostic treatments such as infections, and cancer; or chronic diseases such as those related to inflammation and auto-immunity. We achieve this by repurposing off-the-shelf electronic components augmented with AI to develop cutting-edge proprietary technology (patent pending).

Algocyte

How do we take scientific & technological power to support medical organisations and medical professionals and thereby ultimately the patient? We think that this should be done bottom-up, by supporting, enhancing and eventually replacing old practices by current, more accurate, and cheaper practices supported by technology such as artificial intelligence (AI). However, not any AI is suitable for health where extra care is due. AI for healthcare has to be of a different (and clever) nature, and it has to be interpretable, as in a medical model of diagnosis and prognosis.  OIA's flagship product, Algocyte​, opens a window towards the future of large-coverage AI-based medicine.

​With over two thousand members, our AI meetup groups in the UK are among the largest in their cities and it demonstrates our engagement to connect the academic and industrial communities:

London

Reading

Oxford